Highlights
- •We studied anti-seizure medicine (ASM) trends in Japanese pregnancies with epilepsy.
- •The most commonly prescribed drugs: levetiracetam, lamotrigine, and valproic acid.
- •Levetiracetam and lamotrigine prescriptions have increased over time.
- •There was no temporal change in the prescription of valproic acid.
- •ASM prescriptions have shifted to ASMs with lower teratogenic risk.
Abstract
Purpose
Methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Seizure - European Journal of EpilepsyReferences
- Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland epilepsy and pregnancy registers.J Neurol Neurosurg Psychiatry. 2014; 85: 1029-1034https://doi.org/10.1136/jnnp-2013-306318
Japanese Society of Neurology. Epilepsy practice guidelines 2018, https://www.neurology-jp.org/guidelinem/tenkan_2018.html; 2018 [accessed 7 September 2021].
National Institute for Health and Care Excellence. Epilepsies: diagnosis and management clinical guideline [CG137], https://www.nice.org.uk/guidance/cg137/chapter/1-Guidance#women-and-girls-with-epilepsy; 2021 [accessed 7 September 2021].
- Twenty-year trends in the use of anti-seizure medication among pregnant women in the Netherlands.Epilepsy Behav. 2022; 127108549https://doi.org/10.1016/j.yebeh.2021.108549
- Examination of the prescription of antiepileptic drugs to prenatal and postpartum women in Japan from a health administrative database.Pharmacoepidemiol Drug Saf. 2019; 28: 804-811https://doi.org/10.1002/pds.4749
- Prevalence trends and individual patterns of antiepileptic drug use in pregnancy 2006–2016: a study in the five Nordic countries, United States, and Australia.Pharmacoepidemiol Drug Saf. 2020; 29: 913-922https://doi.org/10.1002/pds.5035
- Drug prescription for attention deficit hyperactivity disorder drugs in pediatric outpatients: a retrospective survey of Japanese administrative data (2012-2018).Asian J Psychiatr. 2021; 57102512https://doi.org/10.1016/j.ajp.2020.102512
World Health Organization. International statistical classification of diseases and related health problems, https://www.who.int/standards/classifications/classification-of-diseases; 2021 [accessed 7 September 2021].
- European federation of neurological societies. EFNS guideline on the drug treatment of migraine–revised report of an EFNS task force.Eur J Neurol. 2009; 16: 968-981https://doi.org/10.1111/j.1468-1331.2009.02748.x
Japanese Headache Society. Guideline for migraine treatment by valproic acid, https://www.neurology-jp.org/guidelinem/ch/documents/appendix-II.pdf; 2013 [accessed 1 April 2022].
American Epilepsy Society. Epilepsies: position statement on the use of valproate by women of childbearing potential, https://cms.aesnet.org/about/position-statements/position-statement-on-the-use-of-valproate-by-women-of-childbearing-potential; 2021 [accessed 7 September 2021].
Pharmaceuticals and Medical Devices Agency. Compliance with dosage and administration and ensuring early detection for Lamictal tablets (lamotrigine)-induced serious skin disorders, https://www.pmda.go.jp/files/000153788.pdf; 2012 [accessed 1 April 2022].
